• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recognition of thrombotic risk of thrombocytosis in iron deficiency.

作者信息

Al-Samkari Hanny, Kessler Craig M, Auerbach Michael

机构信息

Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Department of Medicine, Georgetown University School of Medicine, Washington, DC.

出版信息

Haematologica. 2021 Mar 1;106(3):661-663. doi: 10.3324/haematol.2020.270496.

DOI:10.3324/haematol.2020.270496
PMID:33645945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7927881/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d242/7927881/9bbcad23b6c5/106661.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d242/7927881/9bbcad23b6c5/106661.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d242/7927881/9bbcad23b6c5/106661.fig1.jpg

相似文献

1
Recognition of thrombotic risk of thrombocytosis in iron deficiency.缺铁性血小板增多症血栓形成风险的认识。
Haematologica. 2021 Mar 1;106(3):661-663. doi: 10.3324/haematol.2020.270496.
2
Iron deficiency and thrombosis: literature review.缺铁与血栓形成：文献综述
Clin Appl Thromb Hemost. 2004 Oct;10(4):387-91. doi: 10.1177/107602960401000412.
3
Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia.缺铁性贫血患者继发反应性血小板增多症导致腹主动脉血栓形成。
Ann Hematol. 2016 Aug;95(8):1389-90. doi: 10.1007/s00277-016-2715-x. Epub 2016 Jun 2.
4
Stroke in the young: relationship with iron deficiency anemia and thrombocytosis.年轻人中的中风：与缺铁性贫血和血小板增多症的关系。
Mymensingh Med J. 2008 Jan;17(1):74-7.
5
Pseudothrombocytosis due to microerythrocytosis: a case of beta thalassemia minor complicated with iron deficiency anemia.小细胞性红细胞增多症所致假性血小板增多症：1例轻型β地中海贫血合并缺铁性贫血病例
Acta Haematol. 2013;130(2):61-3. doi: 10.1159/000346434.
6
Neutrophil hypersegmentation and thrombocytosis in children with iron deficiency anemia.缺铁性贫血患儿的中性粒细胞核分叶过多及血小板增多
Turk J Pediatr. 2005 Jul-Sep;47(3):251-4.
7
Carotid artery thrombus associated with severe iron-deficiency anemia and thrombocytosis.与严重缺铁性贫血和血小板增多症相关的颈动脉血栓形成。
Stroke. 1996 May;27(5):1002-5. doi: 10.1161/01.str.27.5.1002.
8
Thrombocytosis in children with iron deficiency anemia: series of 42 children.缺铁性贫血患儿的血小板增多症：42例患儿系列研究
J Pediatr Hematol Oncol. 2002 Oct;24(7):593. doi: 10.1097/00043426-200210000-00025.
9
Iron deficiency-induced thrombocytosis increases thrombotic tendency in rats.缺铁性血小板增多症增加大鼠的血栓形成倾向。
Haematologica. 2021 Mar 1;106(3):782-794. doi: 10.3324/haematol.2019.245092.
10
[Iron deficiency, thrombocytosis and thromboembolism].[缺铁、血小板增多症与血栓栓塞]
Wien Med Wochenschr. 2016 Oct;166(13-14):437-446. doi: 10.1007/s10354-016-0514-6. Epub 2016 Sep 28.

引用本文的文献

1
Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling for Iron-Regulated Hematopoietic Stem and Progenitor Cells' Commitment toward Erythroid and Megakaryocytic Lineages.基于机制的铁调节造血干细胞和祖细胞向红系和巨核系分化的药代动力学/药效学建模
ACS Pharmacol Transl Sci. 2025 May 30;8(6):1711-1725. doi: 10.1021/acsptsci.5c00097. eCollection 2025 Jun 13.
2
How I treat bleeding in hereditary hemorrhagic telangiectasia.我如何治疗遗传性出血性毛细血管扩张症的出血。
Blood. 2024 Aug 29;144(9):940-954. doi: 10.1182/blood.2023021765.
3
Acute aortic intraluminal thrombus with embolisation and lower-limb ischaemia following intravenous iron sucrose infusion reaction.

本文引用的文献

1
Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia.缺铁性贫血中血小板增多症的发生率、预测因素及血栓形成并发症的特征
Am J Hematol. 2020 Oct;95(10):1180-1186. doi: 10.1002/ajh.25925. Epub 2020 Aug 4.
2
Iron deficiency-induced thrombocytosis increases thrombotic tendency in rats.缺铁性血小板增多症增加大鼠的血栓形成倾向。
Haematologica. 2021 Mar 1;106(3):782-794. doi: 10.3324/haematol.2019.245092.
3
A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC.
静脉注射蔗糖铁后发生急性主动脉腔内血栓形成伴栓塞及下肢缺血。
BMJ Case Rep. 2023 Sep 27;16(9):e255702. doi: 10.1136/bcr-2023-255702.
4
Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review.遗传性出血性毛细血管扩张症的抗凝和抗血小板治疗：范围综述。
Thromb Res. 2023 Jun;226:150-155. doi: 10.1016/j.thromres.2023.04.017. Epub 2023 May 3.
5
Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的抗凝和抗血小板治疗的安全性、耐受性和有效性。
J Thromb Haemost. 2023 Jan;21(1):26-36. doi: 10.1016/j.jtha.2022.09.003. Epub 2022 Dec 22.
6
Iron deficiency anemia and thrombosis risk in children-revisiting an old hypothesis.儿童缺铁性贫血与血栓形成风险——重新审视一个旧假说
Front Pediatr. 2022 Aug 1;10:926925. doi: 10.3389/fped.2022.926925. eCollection 2022.
一项达贝泊汀α治疗晚期 NSCLC 化疗相关性贫血的长期安全性和疗效的随机、双盲、安慰剂对照 III 期非劣效性研究
J Thorac Oncol. 2020 Feb;15(2):190-202. doi: 10.1016/j.jtho.2019.10.005. Epub 2019 Oct 16.
4
The safety of intravenous iron preparations: systematic review and meta-analysis.静脉铁制剂的安全性：系统评价和荟萃分析。
Mayo Clin Proc. 2015 Jan;90(1):12-23. doi: 10.1016/j.mayocp.2014.10.007. Epub 2014 Oct 30.
5
Iron deficiency anemia: a common and curable disease.缺铁性贫血：一种常见且可治愈的疾病。
Cold Spring Harb Perspect Med. 2013 Jul 1;3(7):a011866. doi: 10.1101/cshperspect.a011866.
6
Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.癌症化疗引起贫血患者的血小板增多和静脉血栓栓塞症可能与 ESA 引起的铁受限红细胞生成有关，并可通过静脉铁剂治疗逆转。
Am J Hematol. 2012 Mar;87(3):308-10. doi: 10.1002/ajh.22262. Epub 2012 Jan 20.
7
Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.静脉血栓形成风险：肥胖及其与口服避孕药使用和血栓形成前突变的联合作用。
Br J Haematol. 2007 Oct;139(2):289-96. doi: 10.1111/j.1365-2141.2007.06780.x.
8
Clinical update: intravenous iron for anaemia.临床进展：静脉注射铁剂治疗贫血
Lancet. 2007 May 5;369(9572):1502-1504. doi: 10.1016/S0140-6736(07)60689-8.
9
Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.对于正在接受化疗的贫血癌症患者，静脉注射葡萄糖酸铁与口服铁剂或不使用铁剂相比，能显著提高对促红细胞生成素α的反应。
Oncologist. 2007 Feb;12(2):231-42. doi: 10.1634/theoncologist.12-2-231.
10
The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply.重组人促红细胞生成素对血小板计数的影响受到铁供应充足程度的强烈调节。
Blood. 1999 May 15;93(10):3286-93.